HUMANA INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $129.7B | $117.8B | $106.4B | $92.9B | $83.1B |
| Selling, general & administrative | $15.4B | $13.7B | $13.2B | $12.7B | $10.1B |
| Operating income | $2.7B | $2.6B | $4.0B | $3.8B | $3.1B |
| Interest expense | $631.0M | $660.0M | $493.0M | $401.0M | $326.0M |
| Pretax income | $1.6B | $1.7B | $3.4B | $3.6B | $3.4B |
| Income tax expense | $250.0M | $413.0M | $836.0M | $762.0M | $485.0M |
| Net income | $1.2B | $1.2B | $2.5B | $2.8B | $2.9B |
| Balance Sheet | |||||
| Cash and equivalents | $4.2B | $2.2B | $4.7B | $5.1B | $3.4B |
| Current assets | $32.7B | $29.8B | $30.0B | $26.2B | $24.9B |
| Total assets | $48.9B | $46.5B | $47.1B | $43.1B | $44.4B |
| Current liabilities | $16.3B | $16.9B | $18.9B | $17.2B | $15.3B |
| Total liabilities | $31.2B | $30.0B | $30.7B | $27.7B | $28.3B |
| Stockholders' equity | $17.7B | $16.4B | $16.3B | $15.3B | $16.1B |
| Cash Flow Statement | |||||
| Cash from operations | $921.0M | $3.0B | $4.0B | $4.6B | $2.3B |
| Depreciation and amortization | $773.0M | $908.0M | $850.0M | $749.0M | $640.0M |
| Stock-based compensation | $241.0M | $207.0M | $175.0M | $216.0M | $180.0M |
| Capital expenditure | $546.0M | $575.0M | $1.0B | $1.1B | $1.3B |
| Free cash flow | $375.0M | $2.4B | $3.0B | $3.5B | $920.0M |
| Dividends paid | $430.0M | $431.0M | $431.0M | $392.0M | $354.0M |
| Share repurchases | $151.0M | $817.0M | $1.6B | $2.1B | $79.0M |
| Impairments | $253.0M | $200.0M | $91.0M | $0 | $0 |
Shares outstanding 120.1M · Free float 94.5%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.
Recent filings
- June 1, 2026 8-K
- May 19, 2026 8-K
- April 29, 2026 10-Q
- April 29, 2026 8-K
- April 20, 2026 8-K
- April 10, 2026 8-K
- March 9, 2026 8-K
- March 2, 2026 8-K